Figure 3.High expression of NFYB is associated with poor prognosis of GC. (A) Overall survival analysis based on NFYB expression of GC patients in TCGA data. (B) Disease-free survival analysis based on NFYB expression of GC patients in TCGA data. (C) Progression-free survival analysis based on NFYB expression of GC patients in TCGA data. (D) Overall survival analysis based on NFYB expression of GC patients in the Kaplan-Meier plotter database with GEO datasets. (E) Disease Free Survival based on NFYB expression of GC patients in the Kaplan-Meier plotter database with GEO datasets. (F) Progression-free survival analysis based on NFYB expression of GC patients in the Kaplan-Meier plotter database with GEO datasets.
